Systemic JIA: Tapering canakinumab feasible in children in complete remission
For paediatric patients who achieved complete remission (CR) on canakinumab, it is possible to maintain this response while reducing exposure to the drug, as shown in a study.
Systemic JIA: Tapering canakinumab feasible in children in complete remission
03 Sep 2020
